INJECTION SITE NECROSIS

This adverse event was reported 2039 times

These drugs are most commonly taken by patients reporting INJECTION SITE NECROSIS:

# Drug Count
0 GLATIRAMER ACETATE 385
1 INTERFERON BETA-1A 196
2 INTERFERON BETA-1B 134
3 BUPRENORPHINE 103
4 DICLOFENAC SODIUM 94
5 NALTREXONE 74
6 FULVESTRANT 54
7 GABAPENTIN 49
8 APOMORPHINE HYDROCHLORIDE 43
9 DICLOFENAC 40
See all common drugs associated with INJECTION SITE NECROSIS

INJECTION SITE NECROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MOTIXAFORTIDE 4 0.0392
1 ICHTHAMMOL OINTMENT 1 0.0263
2 METHYL SALICYLATE, MENTHOL, CAPSAICIN 1 0.0256
3 APOMORPHINE HYDROCHLORIDE 43 0.0255
4 PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE 1 0.0123
5 DEOXYCHOLIC ACID 28 0.0120
6 TOLCAPONE 3 0.0085
7 NEFAZODONE HYDROCHLORIDE 1 0.0083
8 INTERFERON BETA-1B 134 0.0070
9 GLATIRAMER ACETATE 385 0.0065
See all drugs enriched for association with INJECTION SITE NECROSIS

INJECTION SITE NECROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytolytic Agent [EPC] 28 0.0120
1 Sclerosing Agent [EPC] 3 0.0067
2 Interleukin-5 Antagonist [EPC] 2 0.0029
3 Aldehyde Dehydrogenase Inhibitor [EPC] 2 0.0018
4 Skin Test Antigen [EPC] 3 0.0016
5 Human Immunoglobulin G [EPC] 33 0.0016
6 Estrogen Receptor Antagonist [EPC] 54 0.0013
7 Photoenhancer [EPC] 5 0.0013
8 Catechol-O-Methyltransferase Inhibitor [EPC] 6 0.0012
9 Lipid Emulsion [EPC] 3 0.0011
See all drug classes enriched for association with INJECTION SITE NECROSIS